Annual Non Current Assets
$929.30 K
+$872.60 K+1538.98%
31 December 2023
Summary:
Cyclo Therapeutics annual long term assets is currently $929.30 thousand, with the most recent change of +$872.60 thousand (+1538.98%) on 31 December 2023. During the last 3 years, it has risen by +$844.80 thousand (+999.76%). CYTH annual non current assets is now -62.44% below its all-time high of $2.47 million, reached on 31 December 2011.CYTH Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$2.00 M
+$1.73 M+646.10%
30 September 2024
Summary:
Cyclo Therapeutics quarterly long term assets is currently $2.00 million, with the most recent change of +$1.73 million (+646.10%) on 30 September 2024. Over the past year, it has increased by +$1.07 million (+114.93%). CYTH quarterly non current assets is now -19.27% below its all-time high of $2.47 million, reached on 31 December 2011.CYTH Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTH Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +114.9% |
| 3 y3 years | +999.8% | +2263.7% |
| 5 y5 years | +498.8% | +1186.9% |
CYTH Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1539.0% | at high | +3422.6% |
| 5 y | 5 years | at high | +1539.0% | at high | +3422.6% |
| alltime | all time | -62.4% | +1539.0% | -19.3% | +3422.6% |
Cyclo Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $2.00 M(+646.1%) |
| June 2024 | - | $267.70 K(-54.9%) |
| Mar 2024 | - | $593.80 K(-36.1%) |
| Dec 2023 | $12.32 M(+196.2%) | $929.30 K(+985.6%) |
| Sept 2023 | - | $85.60 K(-9.6%) |
| June 2023 | - | $94.70 K(-8.8%) |
| Mar 2023 | - | $103.80 K(+83.1%) |
| Dec 2022 | $4.16 M(-78.6%) | $56.70 K(-13.7%) |
| Sept 2022 | - | $65.70 K(+1.4%) |
| June 2022 | - | $64.80 K(-12.3%) |
| Mar 2022 | - | $73.90 K(-12.5%) |
| Dec 2021 | $19.44 M(+38.3%) | $84.50 K(-19.1%) |
| Sept 2021 | - | $104.40 K(-15.0%) |
| June 2021 | - | $122.80 K(+2.2%) |
| Mar 2021 | - | $120.20 K(-12.7%) |
| Dec 2020 | $14.05 M(+255.0%) | $137.70 K(-14.2%) |
| Sept 2020 | - | $160.40 K(-7.9%) |
| June 2020 | - | $174.20 K(-7.7%) |
| Mar 2020 | - | $188.80 K(+21.6%) |
| Dec 2019 | $3.96 M(+42.9%) | $155.20 K(-10.1%) |
| Sept 2019 | - | $172.60 K(-8.0%) |
| June 2019 | - | $187.60 K(-13.8%) |
| Mar 2019 | - | $217.60 K(+46.8%) |
| Dec 2018 | $2.77 M(+46.1%) | $148.20 K(-7.5%) |
| Sept 2018 | - | $160.20 K(-6.7%) |
| June 2018 | - | $171.70 K(-9.2%) |
| Mar 2018 | - | $189.10 K(-2.0%) |
| Dec 2017 | $1.90 M(+15.9%) | $192.90 K(-5.7%) |
| Sept 2017 | - | $204.60 K(-3.7%) |
| June 2017 | - | $212.40 K(-3.7%) |
| Mar 2017 | - | $220.60 K(-5.3%) |
| Dec 2016 | $1.64 M(-35.2%) | $233.00 K(-80.8%) |
| Sept 2016 | - | $1.22 M(-42.2%) |
| June 2016 | - | $2.10 M(-2.6%) |
| Mar 2016 | - | $2.16 M(-2.7%) |
| Dec 2015 | $2.52 M(-17.3%) | $2.22 M(-4.3%) |
| Sept 2015 | - | $2.32 M(-2.4%) |
| June 2015 | - | $2.37 M(+0.9%) |
| Mar 2015 | - | $2.35 M(+5.2%) |
| Dec 2014 | $3.05 M(+392.7%) | $2.24 M(-0.2%) |
| Sept 2014 | - | $2.24 M(+1.2%) |
| June 2014 | - | $2.21 M(+3.5%) |
| Mar 2014 | - | $2.14 M(-1.6%) |
| Dec 2013 | $618.90 K(+103.5%) | $2.17 M(-0.5%) |
| Sept 2013 | - | $2.18 M(+2.7%) |
| June 2013 | - | $2.12 M(-5.2%) |
| Mar 2013 | - | $2.24 M(-3.2%) |
| Dec 2012 | $304.20 K | $2.31 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $2.39 M(-1.4%) |
| June 2012 | - | $2.43 M(-0.1%) |
| Mar 2012 | - | $2.43 M(-1.9%) |
| Dec 2011 | $316.30 K(-13.6%) | $2.47 M(+10.1%) |
| Sept 2011 | - | $2.25 M(+16.2%) |
| June 2011 | - | $1.93 M(+18.1%) |
| Mar 2011 | - | $1.64 M(+4.6%) |
| Dec 2010 | $366.20 K(-35.1%) | $1.57 M(+4.4%) |
| Sept 2010 | - | $1.50 M(+46.8%) |
| June 2010 | - | $1.02 M(+25.7%) |
| Mar 2010 | - | $812.70 K(+11.2%) |
| Dec 2009 | $564.60 K(+9.3%) | $730.90 K(+0.3%) |
| Sept 2009 | - | $728.70 K(-0.8%) |
| June 2009 | - | $734.40 K(+0.4%) |
| Mar 2009 | - | $731.80 K(+2.4%) |
| Dec 2008 | $516.40 K(-11.2%) | $714.90 K(-23.3%) |
| Sept 2008 | - | $931.60 K(+0.7%) |
| June 2008 | - | $924.70 K(+2.4%) |
| Mar 2008 | - | $902.70 K(-11.3%) |
| Dec 2007 | $581.30 K(+80.5%) | $1.02 M(+131.2%) |
| Sept 2007 | - | $440.00 K(+3.1%) |
| June 2007 | - | $426.60 K(+0.7%) |
| Mar 2007 | - | $423.60 K(-3.4%) |
| Dec 2006 | $322.10 K(+15.7%) | $438.30 K(-12.0%) |
| Sept 2006 | - | $498.30 K(+0.4%) |
| June 2006 | - | $496.50 K(+3.1%) |
| Mar 2006 | - | $481.60 K(-0.9%) |
| Dec 2005 | $278.40 K(+2.4%) | $485.90 K(-33.7%) |
| Sept 2005 | - | $733.40 K(-1.3%) |
| June 2005 | - | $742.90 K(-0.5%) |
| Mar 2005 | - | $746.80 K(+1.2%) |
| Dec 2004 | $271.80 K(+1.0%) | $738.10 K(+0.3%) |
| Sept 2004 | - | $735.90 K(+1.4%) |
| June 2004 | - | $725.50 K(+19.4%) |
| Mar 2004 | - | $607.50 K(+2.3%) |
| Dec 2003 | $269.20 K(+83.5%) | $593.80 K(+58.7%) |
| Sept 2003 | - | $374.20 K(+2.5%) |
| June 2003 | - | $365.20 K(+5.7%) |
| Mar 2003 | - | $345.40 K(+0.7%) |
| Dec 2002 | $146.70 K(+88.8%) | $343.10 K(-0.4%) |
| Sept 2002 | - | $344.50 K(-1.7%) |
| June 2002 | - | $350.60 K(+2.8%) |
| Mar 2002 | - | $341.20 K(-12.6%) |
| Dec 2001 | $77.70 K(-21.0%) | $390.50 K(-1.9%) |
| Sept 2001 | - | $397.90 K(-4.7%) |
| June 2001 | - | $417.70 K(-3.8%) |
| Mar 2001 | - | $434.10 K(-4.3%) |
| Dec 2000 | $98.30 K | $453.50 K(-29.4%) |
| Sept 2000 | - | $642.20 K |
FAQ
- What is Cyclo Therapeutics annual long term assets?
- What is the all time high annual non current assets for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Cyclo Therapeutics?
- What is Cyclo Therapeutics quarterly non current assets year-on-year change?
What is Cyclo Therapeutics annual long term assets?
The current annual non current assets of CYTH is $929.30 K
What is the all time high annual non current assets for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual long term assets is $2.47 M
What is Cyclo Therapeutics quarterly long term assets?
The current quarterly non current assets of CYTH is $2.00 M
What is the all time high quarterly non current assets for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly long term assets is $2.47 M
What is Cyclo Therapeutics quarterly non current assets year-on-year change?
Over the past year, CYTH quarterly long term assets has changed by +$1.07 M (+114.93%)